Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2023-02-06 19:49 Tx date 2023-02-01 |
$ABUS
Arbutus Biopharma Corporation |
Collier, William Hugh
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,511,400
+866,000 vol $2.90 each |
4,139,950 | |
Filed 2023-02-06 19:44 Tx date 2023-02-01 |
$ABUS
Arbutus Biopharma Corporation |
Collier, William Hugh
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+216,500 vol |
216,500 | |
Filed 2023-02-06 08:26 Tx date 2019-06-24 |
$ABUS
Arbutus Biopharma Corporation |
Collier, William Hugh
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-01-20 18:15 Tx date 2022-01-20 |
$ABUS
Arbutus Biopharma Corporation |
Collier, William Hugh
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,213,015
+787,550 vol $2.81 each |
3,273,950 | |
Filed 2021-02-18 09:50 Tx date 2021-02-13 |
$ABUS
Arbutus Biopharma Corporation |
Collier, William Hugh
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,922,750
+675,000 vol $4.33 each |
2,486,400 | |
Filed 2020-09-25 16:07 Tx date 2020-09-23 |
$ABUS
Arbutus Biopharma Corporation |
Collier, William Hugh
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$234,500
+70,000 vol $3.35 each |
1,811,400 | |
Filed 2020-06-01 17:51 Tx date 2020-05-28 |
$ABUS
Arbutus Biopharma Corporation |
Collier, William Hugh
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$878,748
+262,313 vol $3.35 each |
1,741,400 | |
Filed 2020-02-19 14:37 Tx date 2020-02-17 |
$ABUS
Arbutus Biopharma Corporation |
Collier, William Hugh
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+367,087 vol |
1,479,087 | |
Filed 2019-06-27 13:13 Tx date 2019-06-24 |
$ABUS
Arbutus Biopharma Corporation |
Collier, William Hugh
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,424,160
+1,112,000 vol $2.18 each |
1,112,000 | |
Filed 2019-06-27 13:10 Tx date 2019-06-24 |
$ABUS
Arbutus Biopharma Corporation |
Collier, William Hugh
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|